Lewis and Clark Pharmaceuticals, Inc.

  • Founded: 2011
  • CEO: Robert Thompson, PhD
  • Company Size: 6
  • Funding Source: Investor Funded
  • Development Stage: Pre-clinical

Lewis and Clark Pharmaceuticals, Inc. (L&C Pharma) is an early stage drug development company focusing on adenosine receptor-based therapies for a wide range of inflammatory, autoimmune, and other underserved chronic diseases.  L&C Pharma was founded in 2011 by Robert Thompson, Ph.D., an acknowledged world leader in adenosine chemistry. Dr. Thompson has assembled a team of leading experts in pre-clinical development, toxicology, and adenosine receptor pharmacology, physiology and molecular biology to develop novel compounds for chronic indications.